The Global Ownership Puzzle: Mastering Patent Assignments and Recordation Traps in 2026

Last Updated: June 16, 2026 by Simon K., Borderless Founder & IP Professional

Have you ever successfully prosecuted a patent to issuance, only to discover during a multimillion-dollar acquisition that your company does not actually own it? In the fast-paced, high-stakes world of global intellectual property, securing an allowance from an examiner is only half the battle. The other half is ensuring an unbroken, legally ironclad chain of title.

Patent assignment—the legal mechanism by which ownership of an invention is transferred from the creator to a company—seems straightforward on paper. However, the intersection of streamlined United States practices and rigid European formalities creates a dangerous minefield for international applicants.

Let’s decode the terminology on your patent certificate, explore the USPTO’s electronic recordation system, and highlight the disastrous pitfalls awaiting applicants who assume U.S. assignment rules apply overseas.

Decoding the Certificate: Inventor, Applicant, and Assignee

Before diving into the mechanics of transfer, we must define the players. If you look at the front page of a newly issued U.S. patent, you will see three distinct terms that often confuse junior practitioners and corporate executives alike.

• The Inventor: Under U.S. law, an inventor must be a natural human being—the person who actually conceived of the claimed invention. AI cannot be an inventor, and a corporation cannot be an inventor. The inventor is the foundational origin of all patent rights. By default, the moment an invention is conceived, the inventor owns it.
• The Assignee: This is the entity (usually a corporation, university, or holding company) that has legally purchased or been transferred the property rights to the invention from the inventor.
• The Applicant: This term underwent a radical shift thanks to the America Invents Act (AIA). Prior to 2012, U.S. applications generally had to be filed in the name of the human inventors, making them the official applicants. Post-AIA, the system was modernized. Today, the corporate Assignee can file the patent directly in its own name, making the corporation the official “Applicant.”

The Practitioner’s Reality: The Primitive ADS Trap in PCT National Stage

In theory, transitioning a patent application from the PCT International phase to the U.S. National Stage should be administratively seamless. However, in my practice, I frequently encounter one of the most frustrating and archaic administrative traps in U.S. patent prosecution when the identity of the “Applicant” changes during this transition.

When the Applicant entering the U.S. National Stage is different from the Applicant listed on the original PCT publication, you cannot simply record the new assignment and type the new corporate name into the system. The USPTO demands a highly specific, painfully primitive formatting in the Application Data Sheet (ADS) to legally recognize this change.

You are required to literally type out the original PCT applicant’s name, apply a strikethrough to delete it, and then type the new applicant’s name right next to it with an underline.

If you fail to execute this exact visual markup, the consequences are incredibly annoying. The examiner will typically ignore the formatting error for years while examining the technical merits of the patent. The trap finally snaps shut at the very end of the process: right after you receive the Notice of Allowance. Just as the client is celebrating the grant, the USPTO’s Office of Data Management will flag the discrepancy and issue a “Notice to File Corrected Application Papers,” halting the actual issuance of the patent certificate until you submit the properly marked-up ADS.

Frankly, in the era of artificial intelligence and seamless global data transfers, forcing practitioners to manually strikethrough and underline text on a PDF to prove a change in the applicant is a primitive bureaucratic failure on the USPTO’s part. It is a tedious, manual chore, but it is one that I meticulously handle for my clients upfront to ensure they do not face unnecessary administrative roadblocks at the finish line.

The USPTO Approach: Ministerial Recordation and Speed

How does the USPTO handle the transfer of these rights? In stark contrast to many international bodies, the USPTO operates on a system designed for frictionless commercial speed.

When you submit an assignment document to the USPTO’s Electronic Patent Assignment System (EPAS), the Office does not put it under a microscope to verify its legal validity under state contract law. According to MPEP § 313, “The recording of a document is not a determination by the Office of the validity of the document or the effect that document has on the title to an application or a patent.”

The USPTO’s role is purely ministerial. They act as a public bulletin board, recording the document to provide public notice. However, this does not mean recordation is optional or without immense legal weight.

Under 35 U.S.C. § 261, an assignment must be recorded with the USPTO within three months from its date of execution (or prior to a subsequent purchase). If you fail to record it within this window, your unrecorded assignment is completely void against a subsequent buyer who purchases the patent in good faith without knowing about your secret deal.

💡 Forecast Your Portfolio Liabilities: Failing to secure a legally binding assignment means your corporation might end up paying thousands of dollars in government fees to maintain an asset it doesn’t actually own. Ensure your chain of title is secure, and forecast your exact U.S. maintenance fee obligations using our interactive tool:

Launch the U.S. Patent Filing & Maintenance Fee Estimator (Interactive Calculator)

Modern Mechanics: Scans, E-Signatures, and the 2026 Reality

Are we still demanding wet-ink signatures and wax seals? Thankfully, no. The USPTO has aggressively embraced digital workflows. Under current practices governed by 37 C.F.R. § 1.4(d), the USPTO readily accepts electronic signatures (the “S-signature,” formatted between forward slashes, e.g., /John Doe/). Furthermore, the USPTO generally assumes that a scanned PDF of an assignment document is a true, accurate, and original representation of the underlying legal instrument.

While this makes filing incredibly efficient, it also places the burden of rigorous record-keeping entirely on the applicant’s shoulders. If an ownership dispute arises in federal court, relying solely on an S-signature on a scanned PDF—without a rock-solid internal corporate policy proving who typed those slashes—can invite aggressive evidentiary challenges from opposing counsel.

The Global Collision: Where U.S. Practices Fail Overseas

Here is where the true danger lies. Because the USPTO makes assignments so fast and flexible, U.S. practitioners often develop a false sense of security. What happens when a streamlined U.S. assignment crosses the Atlantic?

1. The Dual-Signature Trap

In the United States, an assignment typically only requires the signature of the assignor (the inventor giving away the rights). The USPTO does not require the receiving corporation (the assignee) to sign the document. However, in many European jurisdictions—specifically the UK and France—an assignment is merely a worthless piece of paper unless it is executed by both parties.

⚠️ Pitfall Example: A tech startup in Silicon Valley executes a standard, U.S.-style, inventor-only assignment. A year later, they file a counterpart in the UK. During UK prosecution, an ownership dispute arises. The UK Intellectual Property Office looks at the U.S. assignment and deems it completely invalid under UK law because the corporate assignee never signed it. The startup suddenly realizes they do not own their UK patent rights.

2. The “Right of Priority” Distinction

This is perhaps the most lethal trap for overseas applicants. In the U.S., when an inventor assigns their “rights in the invention,” it is generally presumed they are also transferring the right to claim priority to that initial filing.

The European Patent Office (EPO) treats this very differently. The EPO views the “right to the invention” and the “right to claim priority” as two distinctly separate legal rights.

⚠️ Pitfall Example: A German inventor files a priority application in Germany, then assigns the invention to a U.S. parent company using a standard U.S. assignment form that vaguely transfers “all rights in the invention.” The U.S. company files an international PCT application claiming priority to the German filing. The EPO rejects the priority claim, arguing that the U.S. assignment never explicitly transferred the right of priority. Intervening prior art immediately invalidates the entire European patent family. Rule of thumb: Always explicitly include the phrase “including the right to claim priority” in global assignment templates.

3. Notarization and the Apostille

The USPTO does not strictly require an assignment to be notarized to be recorded (though 35 U.S.C. § 261 notes it provides prima facie evidence of execution). In foreign jurisdictions, however, it is often a hard requirement. Many Asian and Middle Eastern patent offices will reject an assignment entirely unless it is heavily legalized, often requiring notarization followed by an official government Apostille. A scanned PDF of an unnotarized U.S. S-signature will simply not survive scrutiny in these regions.

PCT and EPO Best Practices for 2026

How do you manage this chaos? The golden rule for global portfolios is to resolve ownership discrepancies at the international stage before they fracture into dozens of national problems.

If a change in ownership occurs, record the assignment under PCT Rule 92bis during the international phase. By registering the assignee change centrally with the World Intellectual Property Organization (WIPO) before the 30-month national phase entry deadline, the updated applicant is automatically recognized by almost all designated national offices, saving you from filing 20 separate assignment recordations in 20 different countries.

Furthermore, if you are prosecuting before the European Patent Office, it is absolute best practice to record your dual-signed assignments with the EPO prior to the grant of the patent. Waiting until after the patent grants to record an assignment can severely complicate the European validation process across individual member states.

The Verdict

While the USPTO’s assignment practices favor rapid, electronic, ministerial recordation using inventor-only signatures, relying on these relaxed standards globally is a recipe for disaster. International applicants must proactively utilize dual-party signatures, explicitly transfer priority rights, and leverage PCT Rule 92bis to ensure their chain of title withstands the rigorous formalities of foreign jurisdictions.

About the Author & Editorial Policy

Written by Simon K., a Borderless Founder and IP Professional specializing in U.S. and international patent frameworks. He leverages his experience running a remote California S-Corporation to provide actionable intelligence for global founders.

Disclaimer: Simon K. is a patent law professional and consultant, not a licensed patent attorney or registered patent agent. All content is for informational purposes only and does not establish an attorney-client relationship.